Pfizer in talks over full license for COVID-19 vaccine in Singapore

Pfizer in talks over full license for COVID-19 vaccine in Singapore
Pfizer in talks over full license for COVID-19 vaccine in Singapore Copyright Thomson Reuters 2021
Copyright Thomson Reuters 2021
By Reuters
Share this articleComments
Share this articleClose Button

SINGAPORE - Pfizer Inc is in discussions with Singapore's Health Sciences Authority regarding obtaining a full license application for its COVID-19 vaccine, the company said in response to a query from Reuters.

Pfizer-BioNTech's COVID-19 vaccine has interim authorisation under the pandemic special access route in Singapore. The U.S. Food and Drug Administration granted full approval to the vaccine last month.

Kenneth Mak, Singapore's director of medical services, said in a briefing on Friday Pfizer and Moderna had not submitted applications for full registration to authorities.

Singapore has not made COVID-19 vaccination compulsory, saying the Pfizer and Moderna shots only have emergency approval, although it has limited activities such as eating out for the unvaccinated.

Some experts say full registration could pave the way https://www.reuters.com/business/healthcare-pharmaceuticals/calls-grow-among-experts-singapore-vaccine-mandate-covid-19-spikes-2021-09-21 to make vaccination mandatory.

Share this articleComments

You might also like

Far-right Greek MP arrested after fight in parliament

Nestlé subsidary Perrier destroys two million bottles of water after 'fecal' bacteria discovery

Latest news bulletin | April 24th – Evening